177 related articles for article (PubMed ID: 30783757)
1. Targeted delivery of 20(S)-ginsenoside Rg3-based polypeptide nanoparticles to treat colon cancer.
Qiu R; Qian F; Wang X; Li H; Wang L
Biomed Microdevices; 2019 Feb; 21(1):18. PubMed ID: 30783757
[TBL] [Abstract][Full Text] [Related]
2. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(l-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo.
Zhang Y; Xiao C; Ding J; Li M; Chen X; Tang Z; Zhuang X; Chen X
Acta Biomater; 2016 Aug; 40():243-253. PubMed ID: 27063495
[TBL] [Abstract][Full Text] [Related]
5. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin loaded methoxy poly (ethylene glycol)-block-Poly (L-glutamic acid-co-L-Phenylalanine) nanoparticles against human breast cancer cell.
Ahmad Z; Tang Z; Shah A; Lv S; Zhang D; Zhang Y; Chen X
Macromol Biosci; 2014 Sep; 14(9):1337-45. PubMed ID: 24933015
[TBL] [Abstract][Full Text] [Related]
7. 20(S)-Ginsenoside Rg3-loaded electrospun membranes to prevent postoperative peritoneal adhesion.
Qiu R; Li J; Sun D; Li H; Qian F; Wang L
Biomed Microdevices; 2019 Aug; 21(4):78. PubMed ID: 31414228
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
[TBL] [Abstract][Full Text] [Related]
12. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
13. RETRACTED: mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3.
Cao L; Wang S; Zhang L; Li J
Biomed Pharmacother; 2022 Feb; 146():112608. PubMed ID: 35062071
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity in A431 cells via encapsulation of 20(R)-ginsenoside Rg3 in PLGA nanoparticles.
Zhang S; Liu J; Ge B; Du M; Fu L; Fu Y; Yan Q
Drug Dev Ind Pharm; 2017 Oct; 43(10):1734-1741. PubMed ID: 28581836
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines.
Lee SY; Kim GT; Roh SH; Song JS; Kim HJ; Hong SS; Kwon SW; Park JH
Biosci Biotechnol Biochem; 2009 Apr; 73(4):811-6. PubMed ID: 19352032
[TBL] [Abstract][Full Text] [Related]
16. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of angiopep-2 functionalized Ginsenoside-Rg3 loaded nanoparticles and the effect on C6 Glioma cells.
Su X; Zhang D; Zhang H; Zhao K; Hou W
Pharm Dev Technol; 2020 Mar; 25(3):385-395. PubMed ID: 30601070
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
Geng L; Fan J; Gao QL; Yu J; Hua BJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling.
He BC; Gao JL; Luo X; Luo J; Shen J; Wang L; Zhou Q; Wang YT; Luu HH; Haydon RC; Wang CZ; Du W; Yuan CS; He TC; Zhang BQ
Int J Oncol; 2011 Feb; 38(2):437-45. PubMed ID: 21152855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
